Skip to main content
VXRT
OTC Life Sciences

Vaxart Files Definitive Proxy Materials, Urges Shareholders to Vote for Current Directors Amid Proxy Contest

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
9
Price
$0.63
Mkt Cap
$152.443M
52W Low
$0.261
52W High
$0.845
52W Position info
142% above low
Off High info
25% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

VXRT has more than doubled off its 52-week low of $0.261.

Summary

Vaxart has filed its definitive proxy materials, actively soliciting shareholder votes to re-elect its current board of directors in response to an ongoing proxy contest.


Key Events · Corporate Governance and Compliance · VXRT

  • Definitive Proxy Materials Filed

    Vaxart has filed its definitive proxy statement and form of white proxy card for the 2026 Annual Meeting of Stockholders.

  • Shareholder Vote Solicitation

    The company is actively urging shareholders to vote "For" all six of its highly qualified directors on the white proxy card and to withhold votes for shareholder nominees.

  • Response to Proxy Contest

    This filing is a direct response to an ongoing proxy contest initiated by an activist shareholder group seeking to elect new directors to the board.


Analysis · VXRT · Life Sciences

This filing represents Vaxart's definitive proxy materials and active solicitation of shareholder votes for its upcoming Annual Meeting. It directly addresses the ongoing proxy contest initiated by an activist shareholder group, urging shareholders to support the current board of directors. The outcome of this vote will determine the future leadership and strategic direction of the company.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VXRT was trading at $0.63 on OTC in the Life Sciences sector, with a market capitalization of approximately $152.4M. The 52-week trading range was $0.26 to $0.84. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VXRT - Latest Insights

VXRT
Nov 05, 2026, 4:26 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.365
Real-time Price: $0.355 info
Change: -$0.010 (-3%) info
Market Cap: $79.886M info
VXRT
Nov 05, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.365
Real-time Price: $0.355 info
Change: -$0.010 (-3%) info
Market Cap: $79.886M info
VXRT
Nov 05, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.365
Real-time Price: $0.355 info
Change: -$0.010 (-3%) info
Market Cap: $79.886M info
VXRT
Jul 17, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.515
Real-time Price: $0.355 info
Change: -$0.160 (-31%) info
Market Cap: $79.886M info
VXRT
Jul 07, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.584
Real-time Price: $0.355 info
Change: -$0.229 (-39%) info
Market Cap: $79.886M info